Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services

Interim Report on Immunization Finance Policies and Practices

Committee on Immunization Finance Policies and Practices

Division of Health Care Services

INSTITUTE OF MEDICINE

Washington, D.C.
May 1999



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R1
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services Interim Report on Immunization Finance Policies and Practices Committee on Immunization Finance Policies and Practices Division of Health Care Services INSTITUTE OF MEDICINE Washington, D.C. May 1999

OCR for page R1
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices National Academy Press 2101 Constitution Avenue, N.W. Washington, D.C. 20418 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. The Institute of Medicine was chartered in 1970 by the National Academy Sciences to enlist distinguished members of the appropriate professions in the examination of policy matters pertaining to the health of the public. In this, the Institute acts under both the Academy's 1863 congressional charter responsibility to be an adviser to the federal government and its own initiative identifying issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine. Support for this project was provided by the Centers for Disease Control and Prevention. (Award Number 200199900023). The views presented are those of the Institute of Medicine's Committee on Immunization Finance Policies and Practices and are not necessarily those of the funding organization. Additional copies of this report are available in limited quantities from the Division of Health Care Services, Institute of Medicine, 2101 Constitution Avenue, NW, Washington, DC 20418. The full text of the report is also available on-line at: www.nap.edu For more information about the Institute of Medicine, visit the IOM home page at www.national-academies.org/iom. Copyright 1999 by the National Academy of Sciences. All rights reserved. Printed in the United

OCR for page R1
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices COMMITTEE ON IMMUNIZATION FINANCE POLICIES AND PRACTICES BERNARD GUYER, MD (Chair), Professor and Chair, Department of Population and Family Health Services, Johns Hopkins School of Hygiene and Public Health DAVID SMITH, MD (Vice Chair), President, Texas Tech University Health Sciences Center, Lubbock, TX E. RUSSELL ALEXANDER, MD, Professor Emeritus, Department of Epidemiology, University of Washington GORDON BERLIN, MA, Senior Vice President, Manpower Demonstration Research Corporation, New York, NY STEVE BLACK, MD, Co-Director, Vaccine Study Center, Kaiser Permanente, Oakland, CA SHEILA BURKE, MPA, RN, Executive Dean, John F. Kennedy School of Government, Harvard University JANET CURRIE, PhD, Professor, Department of Economics, University of California, Los Angeles BARBARA DeBUONO, MD, MPH, Chief Executive Officer, New York Presbyterian Healthcare Network, New York, NY GORDON DeFRIESE, PhD., Professor of Social Medicine, Epidemiology, Health Policy, and Administration, University of North Carolina WALTER FAGGETT, MD, Pediatric Consultant, Medlink Hospital, Washington, DC SAMUEL L. KATZ, MD, Wilburt C. Davison Professor Emeritus, Department of Pediatrics, Duke University Medical Center SARA ROSENBAUM, JD, Director, Center for Health Policy Research, School of Public Health and Health Services, George Washington University CATHY SCHOEN, MA, Vice President, Research and Evaluation, The Commonwealth Fund, New York, NY JANE SISK, PhD., Division of Health Policy and Management, Joseph L. Mailman School, Columbia University Institute of Medicine Staff ROSEMARY CHALK, Study Director JANE DURCH, Senior Project Officer HEATHER SCHOFIELD, Project Assistant

OCR for page R1
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices INDEPENDENT REPORT REVIEWERS This report has been reviewed by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council's Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the authors and the Institute of Medicine in making the published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The content of the review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We wish to thank the following individuals for their participation in the review of this report: Barbara J. McNeil, MD, PhD, Department of Health and Care Policy, Harvard Medical School; Velvet Miller, PhD, Children's Futures, Princeton, NJ; Fitzhugh Mullen, MD, Contributing Editor, Health Affairs, Bethesda, MD; Neal Vanselow, MD, Rio Verde, AZ; and Virginia Weldon, MD, Center for the Study of American Business, Washington University, St. Louis, MO. The individuals listed above have provided many constructive comments and suggestions, but responsibility for the final content of this report rests solely with the authoring committee and the Institute of Medicine.